Sigilon Therapeutics (SGTX) Short Interest Ratio & Short Volume Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Sigilon Therapeutics Short Interest DataCurrent Short Interest8,200 sharesPrevious Short Interest10,100 sharesChange Vs. Previous Month-18.81%Dollar Volume Sold Short$171,544.00Short Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2023Outstanding Shares2,510,000 sharesFloat Size1,420,000 sharesShort Percent of Float0.58%Today's Trading Volume83,600 sharesAverage Trading Volume62,902 sharesToday's Volume Vs. Average133% Short Selling Sigilon Therapeutics ? Sign up to receive the latest short interest report for Sigilon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSGTX Short Interest Over TimeSGTX Days to Cover Over TimeSGTX Percentage of Float Shorted Over Time Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! Sigilon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20238,200 shares $171,544.00 -18.8%0.6%0.1 $20.92 7/15/202310,100 shares $214,625.00 -1.0%0.7%0.1 $21.25 6/30/202310,200 shares $229,602.00 +7.4%0.7%0.1 $22.51 6/15/20239,500 shares $48,070.00 +6.7%0.7%1.2 $5.06 5/31/20238,900 shares $37,380.00 -15.2%0.6%0.6 $4.20 5/15/202310,500 shares $69,464.85 -93.3%N/A0.6 $6.62 Get the Latest News and Ratings for SGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sigilon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/2023156,600 shares $114,318.00 +21.8%1.1%0.8 $0.73 4/15/2023128,600 shares $83,590.00 -5.8%0.9%0.6 $0.65 3/31/2023136,500 shares $126,958.65 -26.1%1.0%0.3 $0.93 3/15/2023184,600 shares $210,444.00 -24.9%1.3%0.5 $1.14 2/28/2023245,700 shares $267,813.00 +13.4%1.8%0.9 $1.09 2/15/2023216,700 shares $166,859.00 -5.6%1.0%0.9 $0.77 1/31/2023229,500 shares $166,066.20 +46.9%1.1%1 $0.72 1/15/2023156,200 shares $71,852.00 -5.1%0.7%0.7 $0.46 12/30/2022164,500 shares $57,575.00 -7.0%0.8%3.5 $0.35 12/15/2022176,800 shares $58,344.00 +11.8%0.9%3.7 $0.33 11/30/2022158,200 shares $62,394.08 +6.3%0.8%3.4 $0.39 11/15/2022148,800 shares $67,852.80 -5.9%0.8%3.6 $0.46 10/31/2022158,200 shares $79,416.40 +25.4%1.1%4.1 $0.50 10/15/2022126,200 shares $61,838.00 -9.7%0.9%3.1 $0.49 9/30/2022139,700 shares $70,548.50 -5.7%1.0%3.1 $0.51 9/15/2022148,200 shares $100,776.00 +6.5%1.0%2 $0.68 8/31/2022139,200 shares $86,526.72 +7.7%1.0%1.6 $0.62 8/15/2022129,300 shares $93,108.93 -9.6%0.9%1.3 $0.72 7/31/2022143,100 shares $101,601.00 +9.9%1.0%1.3 $0.71 7/15/2022130,200 shares $108,586.80 -17.3%0.9%1.1 $0.83 6/30/2022157,400 shares $130,642.00 -73.9%1.1%1.3 $0.83 6/15/2022603,300 shares $552,019.50 -9.2%4.3%5 $0.92 5/31/2022664,500 shares $503,691.00 +25.2%4.7%6.7 $0.76 5/15/2022530,600 shares $398,480.60 +11.6%3.7%5.9 $0.75 4/30/2022475,600 shares $499,380.00 +5.5%3.4%5.5 $1.05 4/15/2022450,800 shares $635,628.00 -4.1%3.2%5.1 $1.41 3/31/2022469,900 shares $690,753.00 +15.7%3.3%4.9 $1.47 3/15/2022406,200 shares $548,370.00 +13.3%2.9%3.9 $1.35 2/28/2022358,500 shares $519,825.00 +11.5%2.5%3 $1.45 2/15/2022321,500 shares $524,045.00 +31.8%2.3%2.3 $1.63 1/31/2022244,000 shares $475,800.00 +9.7%1.7%1.7 $1.95 1/15/2022222,400 shares $489,280.00 -4.7%1.6%1.5 $2.20 12/31/2021233,400 shares $644,184.00 -3.7%1.7%1.7 $2.76 12/15/2021242,400 shares $625,392.00 -15.5%1.7%1.8 $2.58New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! 11/30/2021286,700 shares $1.08 million -31.7%2.1%2.2 $3.76 11/15/2021419,900 shares $2.14 million -37.0%3.0%2.9 $5.09 10/29/2021666,000 shares $3.59 million +7.0%4.8%4.1 $5.39 10/15/2021622,400 shares $3.45 million -19.9%4.5%3.5 $5.55 9/30/2021777,400 shares $4.39 million +1.0%5.6%3.7 $5.65 9/15/2021769,400 shares $4.42 million -6.9%5.5%2.9 $5.75 8/31/2021826,800 shares $4.91 million +6.7%6.1%2.9 $5.94 8/13/2021775,000 shares $4.12 million -3.4%5.7%2.8 $5.32 7/30/2021802,400 shares $4.04 million -18.7%6.0%3.2 $5.04 7/15/2021987,000 shares $5.93 million +54.0%7.4%4.4 $6.01 6/30/2021641,000 shares $6.88 million +76.3%4.8%3.2 $10.73 6/15/2021363,500 shares $3.74 million -25.2%2.7%2.6 $10.29 5/28/2021485,900 shares $5.67 million -1.7%3.6%4 $11.67 5/14/2021494,500 shares $6.55 million +9.9%3.7%4.5 $13.25 4/30/2021450,100 shares $6.63 million -14.9%3.4%3.7 $14.74 4/15/2021528,700 shares $10.51 million -7.4%4.0%4.3 $19.88 3/31/2021571,000 shares $10.71 million +176.8%4.6%4.4 $18.76 3/15/2021206,300 shares $6.01 million +60.7%1.7%1.5 $29.15 2/26/2021128,400 shares $3.51 million +46.4%1.1%0.8 $27.32 2/12/202187,700 shares $3.49 million +49.2%0.7%0.5 $39.81 1/29/202158,800 shares $1.81 million +25.6%0.5%0.3 $30.74 1/15/202146,800 shares $1.60 million No Change0.4%0.2 $34.16 SGTX Short Interest - Frequently Asked Questions What is Sigilon Therapeutics' current short interest? Short interest is the volume of Sigilon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 8,200 shares of SGTX short. 0.58% of Sigilon Therapeutics' shares are currently sold short. Learn More on Sigilon Therapeutics' current short interest. What is a good short interest percentage for Sigilon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Sigilon Therapeutics' floating shares are currently sold short. Is Sigilon Therapeutics' short interest increasing or decreasing? Sigilon Therapeutics saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 8,200 shares, a decline of 18.8% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sigilon Therapeutics' float size? Sigilon Therapeutics currently has issued a total of 2,510,000 shares. Some of Sigilon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sigilon Therapeutics currently has a public float of 1,420,000 shares. How does Sigilon Therapeutics' short interest compare to its competitors? 0.58% of Sigilon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sigilon Therapeutics: Shattuck Labs, Inc. (9.13%), Abeona Therapeutics Inc (7.95%), Generation Bio Co. (3.93%), Trevi Therapeutics, Inc. (1.80%), Greenwich LifeSciences, Inc. (6.54%), Ventyx Biosciences, Inc. (15.87%), G1 Therapeutics, Inc. (13.45%), Biomea Fusion, Inc. (28.41%), Renovaro Inc. (4.64%), XBiotech Inc. (4.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sigilon Therapeutics stock? Short selling SGTX is an investing strategy that aims to generate trading profit from Sigilon Therapeutics as its price is falling. SGTX shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sigilon Therapeutics? A short squeeze for Sigilon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGTX, which in turn drives the price of the stock up even further. How often is Sigilon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGTX, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Shattuck Labs Short Interest Data Abeona Therapeutics Short Interest Data Generation Bio Short Interest Data Trevi Therapeutics Short Interest Data Greenwich LifeSciences Short Interest Data Ventyx Biosciences Short Interest Data G1 Therapeutics Short Interest Data Biomea Fusion Short Interest Data Renovaro Short Interest Data XBiotech Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigilon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sigilon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.